Large Dosage of Chishao in Formulae for Cholestatic Hepatitis: A Systematic Review and Meta-Analysis

الملخص EN

Objective.

To evaluate the efficacy and safety of large dosage of Chishao in formulae for treatment of cholestatic hepatitis.

Methods.

The major databases (PubMed, Embase, Cochrane Library, Chinese Biomedical Database Wanfang, VIP medicine information system, and China National Knowledge Infrastructure) were searched until January 2014.

Randomized controlled trials (RCTs) of large dosage of Chishao in formulae that reported on publications in treatment of cholestatic hepatitis with total efficacy rate, together with the biochemical indices including alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin (TBIL), and direct bilirubin (DBIL), were extracted by two reviewers.

The Cochrane tool was used for the assessment of risk of bias included trials.

Data were analyzed with RevMan 5.2.7 software.

Results.

11 RCTs involving 1275 subjects with cholestatic hepatitis were included.

Compared with essential therapy, large dosage of Chishao in formulae demonstrated more efficiently with down regulation of serum ALT, AST, TBIL, DBIL.

Meanwhile, there were no obvious adverse events.

Conclusion.

As a promising novel treatment approach, widely using large dosage of Chishao in formulae may enhance the curative efficacy for cholestatic hepatitis.

Considering being accepted by more and more practitioners, further rigorously designed clinical studies are required.